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LETTERS TO THE EDITOR 
Surgical interruption of the superior vena cava 
To the Editor: 
We read with interest he article by Gonzales-Fajardo 
and associates on complications arising from surgical 
interruption of the superior vena cava (SVC) (J TnORAC 
CARDIOVASC Sug~ 1994;107:1044-9) and fully support he 
conclusions regarding the dangers of acute interruption of 
the SVC. 
During the past 18 months we have routinely used the 
Invos 3100 regional cerebral oximeter (Somanetics Inc., 
Troy, Mich.) in more than 230 patients having cardiac 
surgery at our institution. The monitor uses near infrared 
spectrophotometry to measure regional cerebral oxyhe- 
moglobin saturation (rSOe) beneath a forehead-mounted 
sensor. During one such operation (patch closure of a 
secundum atrial septal defect, carried out by a trainee 
under consultant supervision), the SVC cannula was 
pulled back into the right atrium before discontinuation f 
bypass. Unfortunately, unbeknown to the consultant, he 
trainee then tightened the vascular tourniquet around the 
SVC, completely occluding this vessel. Within seconds, 
the rSO2 reading had dropped from 63% to 37% and the 
monitor alarm sounded. Peffusion pressure and pump 
flow were satisfactory, and the pulse oximeter reading was 
100%. A search of the operative field revealed the error 
and the tourniquet was released after approximately 11/2 
minutes of complete SVC occlusion. The rSO2 reading 
rose to 65% within 1 minute, and no cerebral sequelae 
resulted. 
This case supports the findings of Gonzales-Fajardo 
and colleagues in their animal studies, which revealed 
serious cerebral consequences associated with acute 
SVC occlusion and suggested that rSO2 monitoring 
offers a method of detecting such venous obstruction in 
clinical practice, even though the perfusion/oxygenation 
side of the cerebral circulation is generally of mõre 
immediate concern. Furthermore, we suggest that mon- 
itoring rSO2 allows the surgeon to observe the effect of 
temporary SVC clamping and thus determine the need 
for shunting on the basis of whether there is a signifi- 
cant drop in rSO 2. 
In clinical practice, shunting will not be necessary in 
some patients because of the development of collateral 
vessels. In these, the rSO 2 reading would be expected to 
remain unchanged uring temporary SVC occlusion. 
Ian J. Reece, FRCS 
Habib A1 Tareif FRCS 
The Mohamad bin Khalifa bin Sulman 
AI Khalifa Cardiac Centre 
P.O. Box 28743 
Bahrain 
[Postscript] We would like to point out that there is 
considerable evidence that the Invos 3100 oximeter does 
measure the oxyhemoglobin saturation of cerebral tissue 
under the sensor rather than that of superficial tissues. 
Cerebral saturation is clearly related to both blood flow 
1020 
and oxygen content, but in the case of acute SVC occlu- 
sion it is the change in arteriovenous pressure difference 
in the face of a normal flow that determines the cerebral 
insult. The Invos machine detected this problem in out 
patient and aUowed speedy remedial action. If applied in 
situations in which the SVC is to be deliberately clamped, 
we consider that a significant drop in rSO2 would indicate 
the need for shunting, and we believe that out comments 
are valid. 
12/8/61479 
One-lung ventilation during surgical procedures 
on the main bronchus and carina 
To the Editor: 
In the April issue of the Jouv, NaL we read the l tter by 
Dr. Inoue a concerning the Univent endotracheal tube (Fuji 
Systems Corporation, Tokyo, Japan) and its clinical con- 
ditions of use. In a list of conditions in which the use of 
this tube is inappropriate, the author includes lung lavage, 
differential ung ventilation, and suction of tenacious 
secretions ffom below the bronchial blocker. 
Not mentioned in this list is an important clinical 
condition in which the use of the Univent tube is also 
inappropriate, that is, when bronchoplastic procedures 
in the main bronehus or tracheal carina are required. In 
fact, with this as well as with all other bronchial 
blocker-based systems for one-lung ventilation, 2 the 
bronchial blocker must be positioned in the main 
bronchus of the "surgical" lung, thus occupying the 
space where the surgical procedure may be carried out. 
Through the bronchial blocker, the dependent lung can 
be simply deflated or inflated but not ventilated and 
thus the blocker cannot be positioned in the recumbent, 
"nonsurgieal" ung. 
The problem may be solved with a standard double- 
lumen tube or with an endobronchial tube in which the 
bronchial extremity of the device is large enough to allow 
lung ventilation and thus can be positioned in the recum- 
bent, "nonsurgical" ung. 
We had favorable clinical experience with a method for 
one-lung ventilation developed in out institution (Fig. 1). 3 
The separate ventilation is achieved by means of a cuffed 
endobronchial tube (Portex Ltd, Hithe, Kent, United 
Kingdom), whose tip is positioned in a main bronchus 
after passing through a standard tracheal tube. The tubes 
assembled in this way define two independent channels, 
each in communication with orte lung. The two channels 
are s/zed so that they provide similar resistance to gas 
flow. The distal end of the right endobronchial tube is 
fitted with a side branch originating immediately after the 
cuff, forming a 45-degree angle with the major axis of the 
tube. This branch is inserted into the right upper lobar 
bronchus; in this way the advancement of the tube is 
stopped before its cuff obstructs the origin of the right 
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Fig. 1. The endobronchial tube is inserted into a standard tracheal tube and positioned in the nonsurgical 
stem bronchus, thus allowing space in the event the operation should involve this area. The tubes 
assembled in this way define two independent channels, each connected with one lung. The right tube is 
fitted with a lateral branch to compensate for the anatomic variations in length of the right main bronchus. 
upper lobar bronchus. The left endobronchial tube is 
fitted with a carinal hook. 
This system has advantages imilar to that of Dr. 
Inoue's device, but it allows the availability of the main 
bronchus and the carina for surgical maneuvers. 
A further advantage of this tube is related to the 
particular configuration of the right endobronchial 
tube, whose distal end is fitted with a side branch 
originating immediately after the cuff, forming a 45- 
degree angle with the major axis of the tube. This 
branch is inserted into the right upper lobar bronchus; 
in this way the advancement of the tube is stopped 
before its cuff obstructs the origin of the right upper 
lobar bronchus, compensating for the anatomic vari- 
ability of the length of the right main bronchus. This 
configuration solves a common problem in left lung 
surgery, 4 in which incomplete separation of lung venti- 
lation or poor ventilation of the right upper lobe is a 
common occurrence with standard ouble-lumen tubes. 
A. Fontana, MD 
S. Nazari, MD 
1RCCS San Matteo 
University of Pavia 
Pavia, Italy 
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12/8/59955 
Reply to the Editor: 
I appreciate the research into the area of bronchial 
blockade done by Drs. Fontana and Nazari. When I first 
began to design the Univent tube (Fuji Systems Corpora- 
tion, Tokyo, Japan), my objectives were to create an 
endobronchial tube that was easy to place by clinicians not 
used to such procedures, a device that could ventilate the 
patient's lungs adequately without adding to gas flow 
resistance, and a device that could easily support he use 
of a fiberoptic bronchoscope. I believe the Univent tube 
has achieved these goals. 
My original etter to the Editor 1 explained to surgeons 
the various ways the Univent tube could make lee (in the 
operating room) easier for rhein. 
The types of cases Drs. Fontana and Nazari describe 
are not easy, especially when using a new and perhaps 
unfamiliar device. For these reasons I did not indicate the 
use of Univent tubes for tracheal, carinal, or main-stem 
bronchial resections. I have anecdotal reports of these 
cases being performed with the bronchial umen of the 
Univent tube being used as a "jet stylet," ventilating the 
nonsurgical lung by means of high-frequency jet ventila- 
tion with the blocker cuff deflated to allow for escaping 
gases. These cases were performed by anesthesiologists 
and surgeons well versed in the use of the Univent tube 
and advanced surgical ventilation techniques. 
For the Univent tube to be used properly, as with all 
medical devices, it is wise to start on the easier and more 
routine cases to gain experience. The Univent tube will 
accept standard-sized fiberoptic bronchoscopes for visual- 
ization and placement of the bronchial blocker. If the 
instruction manual is followed, right-sided placement of 
the blocker is safe and simple to perform. 
I designed the Univent tube to simplify the concept of 
the endotracheal tube and balloon occlusion catheter 
technique for lung separation. The tube described by 
Drs. Fontana and Nazari seems to reintroduce the 
difficulties of Fogarty catheters for the surgeon/anes- 
thesiologist. 
Hiroshi Inoue, MD 
First Department of Surgery 
School of Medicine 
Tokai University 
Isehara, Kanagawa 259-1L Japan 
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12/8/61688 
Aprotinin and vein graft occlusion after coronary 
artery bypass 
To the Editor: 
We were interested to read the article by Havel and 
colleagues (J THORAC CARDIOVASC SURG 1994;107:807- 
10), which concluded that aprotinin significantly reduced 
postoperative bleeding without influencing early vein graft 
patency in a series of 45 patients undergoing coronary 
artery bypass. The number of patients in this study is 
inadequate, however, to make any conclusion regarding 
the effect aprotinin may have on the early patency of 
coronary vein gratis. 
The most appropriate method of statistical analysis of 
data concerning vein graft patency has frequently been 
debated, but it seems clear that comparison of rein graft 
patency rates by distal anastomoses alone is inadequate. 
Many factors may influence early graft occlusion, and 
recent studies that have compared the patency and occlu- 
sion of distal anastomoses within patients have shown that 
these are dependent events. 1 It is therefore important 
when investigating the effect of a single variable on vein 
graft patency that a comparison be made of the proportion 
of patients with at least one occluded graft. This important 
point has been made previously, emphasizing the fact that 
individual gratis within a patient are unlikely to behave 
independently. 2 Taking this into account, we have calcu- 
lated that assuming 25% of patients in the control group 
would have one occluded graft or more (from pooled 
data), 290 patients per treatment group would be required 
for a 50% reduction in the risk of occlusion to be detected, 
specifying an alpha error of 5% (two-sided) and a beta 
error of 10%. This is in keeping with the statistical 
estimates of some of the recently published trials regard- 
ing the effect of antiplatelet agents on vein graft occlu- 
sion.3, 4 
Another article published recently addressing the issue 
of aprotinin and vein graft patency found no difference in 
patency rates between treatment and control groups (as 
assessed by ultrafast computed tornography) but con- 
cluded that despite randomizing 216 patients, the num- 
bers were too small to make firm statistical conclusions. » 
The comparison of occlusion rates in 15 patients per 
treatment group as performed by Havel and associates i
therefore inappropriate. Larger trials will have to be 
performed before we can be convinced of their conclu- 
sion. 
M. J. Underwood, MD a 
G. J. Cooper, MD b 
Departments of Cardiac Surgery 
Bristol Royal Infirmary a
Bristol, United Kingdom 
The Brook Hospital b 
London, United Kingdom 
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